Local treatment of breast cancer liver metastasis
R Bale, D Putzer, P Schullian - Cancers, 2019 - mdpi.com
Breast cancer represents a leading cause of death worldwide. Despite the advances in
systemic therapies, the prognosis for patients with breast cancer liver metastasis (BCLM) …
systemic therapies, the prognosis for patients with breast cancer liver metastasis (BCLM) …
Y90 clinical data update: cholangiocarcinoma, neuroendocrine tumor, melanoma, and breast cancer metastatic disease
SA Padia - Techniques in Vascular and Interventional Radiology, 2019 - Elsevier
While the most compelling levels of evidence for the use of Yttrium-90 (90 Y)
radioembolization are in patients with hepatocellular carcinoma and hepatic metastases …
radioembolization are in patients with hepatocellular carcinoma and hepatic metastases …
Intra-arterial mitomycin C infusion in a large cohort of advanced liver metastatic breast cancer patients: safety, efficacy and factors influencing survival
BM Aarts, EG Klompenhouwer, RC Dresen… - Breast Cancer Research …, 2019 - Springer
Purpose The aim of this study was to determine the safety and efficacy of Mitomycin C
(MMC) infusion in a large cohort of advanced liver metastatic breast cancer patients (LMBC) …
(MMC) infusion in a large cohort of advanced liver metastatic breast cancer patients (LMBC) …
Nuclear medicine in the diagnosis and treatment of breast cancer
C Turkmen, ZG Ozkan - Breast Disease: Diagnosis and Pathology, Volume …, 2019 - Springer
In nuclear medicine practice, there have been many diagnostic tools developed for primary
detection, staging, and evaluation of treatment response in breast cancer. Although recent …
detection, staging, and evaluation of treatment response in breast cancer. Although recent …